US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

GSK plc ADRhedged

69.86

0.0000

Volume:10

Turnover:698.66

Market Cap:698.64K

PE:- -

High:69.86

Open:69.86

Low:69.86

Close:69.86

52wk High:85.03

52wk Low:55.03

Shares:10.00K

Float Shares:10.00K

Volume Ratio:0.19

T/O Rate:0.10%

Dividend:2.07

Dividend Rate:2.97%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Sweeping job cuts at GSK to fund £400m Cambridge campus

GSK’s partner posts positive osteosarcoma data for B7-H3 drug, bolstering oncology push

GlaxoSmithKline (GSK) Receives a Hold from Deutsche Bank

GSK’s ViiV Healthcare presents data from Phase IIIb VOGUE study

GSK Strategy Update in Focus

GSK Canada Wins Approval for Prefilled Shingrix Syringe

MT Newswires Live

GSK Plc Expected to Post Earnings of $1.24 a Share - Earnings Preview

Sector Update: Healthcare Stocks Softer Late Afternoon

MT Newswires Live

GSK Gets U.S. Approval for Jideytro for Certain Lung Cancers

GSK’s New Malaria Candidate Advances With Key Drug-Interaction Study

GSK’s ViiV Healthcare to present new data on INSTI-focused portfolio

GSK plc Stock (GSK) Closed Down by 3.17% on Jul 20: Facts Behind the Movement

GSK Updates Key Pediatric Flu Study, Signaling Quiet Upside for Its Antiviral Portfolio

GSK announces EMA accepted submission to update Bexsero label

GSK Cough Drug Failure Disappoints, but Market was Cautious

Dow Jones Top Company Headlines at 7 PM ET: Walmart Further Shuffles Top Executives | SpaceX ...

GSK plc Stock (GSK) Moved Down by 3.06% on Jul 17: Drivers Behind the Movement

GSK’s ALANIS Trial: Fresh Momentum in AL Amyloidosis Could Reshape Investor Views

GSK Explores Heart Health Upside From Its Next-Gen Vaccines

GSK’s New Asthma Injection Study: Early Signals for Long-Term Investors

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/GSKH/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GSKH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GSKH\",,,,,undefined,":{"symbol":"GSKH","market":"US","secType":"STK","nameCN":"GSK plc ADRhedged","latestPrice":69.8569,"timestamp":1788271521437,"preClose":69.8569,"halted":0,"volume":10,"delay":0,"changeRate":0,"floatShares":10001,"shares":10001,"eps":0,"marketStatus":"Trading","change":0,"latestTime":"09-01 10:15:57 EDT","open":69.8569,"high":69.8569,"low":69.8569,"amount":698.6597,"amplitude":0,"askPrice":71,"askSize":100,"bidPrice":70.9,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1788292800000},"marketStatusCode":2,"adr":0,"exchange":"ARCA","adjPreClose":69.8569,"nav":70.443211,"aum":704502.553211,"dividendRate":0.029701,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":70.28,"preClose":69.8569,"latestTime":"16:10 EDT","volume":6,"amount":419.1414,"timestamp":1788207004353,"change":0.4231,"changeRate":0.006057,"amplitude":0},"volumeRatio":0.193391,"impliedVol":0.1633,"impliedVolPercentile":0.3113},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GSKH\",,,,,undefined,":{"symbol":"GSKH","floatShares":10001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.193391,"shares":10001,"dividePrice":2.0748,"high":69.8569,"amplitude":0,"preClose":69.8569,"low":69.8569,"week52Low":55.03,"pbRate":"--","week52High":85.03,"institutionHeld":0,"latestPrice":69.8569,"eps":0,"divideRate":0.029701,"volume":10,"delay":0,"ttmEps":0,"open":69.8569,"prevYearClose":68.2031,"prevWeekClose":70.5267,"prevMonthClose":69.8569,"prevQuarterClose":73.8574,"fiveDayClose":71.8401,"twentyDayClose":71.5353,"sixtyDayClose":73.2013},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GSKH\",params:#limit:5,,,undefined,":[{"date":"2026-06-16","symbol":"GSKH","amount":0.92785,"announcedDate":"2026-06-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-16","defaultRemindTime":1781616600000,"name":"GSK plc ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-23","payableDate":"2026-06-16","currency":"USD","dateTimestamp":1781582400000,"payDate":"2026-06-23"},{"date":"2026-03-16","symbol":"GSKH","amount":0.36332,"announcedDate":"2026-03-13","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-16","defaultRemindTime":1773667800000,"name":"GSK plc ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-23","payableDate":"2026-03-16","currency":"USD","dateTimestamp":1773633600000,"payDate":"2026-03-23"},{"date":"2025-12-16","symbol":"GSKH","amount":0.78682,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"GSK plc ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-24"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GSKH\",market:\"US\",,,undefined,":[{"executeDate":"2025-12-16","recordDate":"2025-12-16","paymentDate":"2025-12-24","value":0.78682,"currency":"USD"},{"executeDate":"2026-03-16","recordDate":"2026-03-16","paymentDate":"2026-03-23","value":0.36332,"currency":"USD"},{"executeDate":"2026-06-16","recordDate":"2026-06-16","paymentDate":"2026-06-23","value":0.92785,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GSKH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GSKH\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2654018880","title":"Sweeping job cuts at GSK to fund £400m Cambridge campus","url":"https://stock-news.laohu8.com/highlight/detail?id=2654018880","media":"cityam","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654018880?lang=en_us&edition=fundamental","pubTime":"2026-07-28 19:02","pubTimestamp":1785236535,"startTime":"0","endTime":"0","summary":"GSK was reducing headcount in its back office to fund the campus GSK is poised to slash its back office headcount to help fund a 400m mega-campus in Cambridge, in a move it hopes will bolster its drugs pipeline and stave off a looming patent cliff edge.In his first major strategy update as chief executive, Luke Miels unveiled plans for the new 300,000 square foot site that will become the new home for its research and development arm and host more than 1,000 GSK scientists.The group is expected to launch a sweeping round of layoffs to help fund the investment and support the firm’s operating margin.Miels hailed the move, which will see it vacate its Stevenage research and development (R&D) site for Cambridge by 2029, as a shot in the arm for the FTSE 100 giant, which has lagged behind London-listed rival Astrazeneca and US peers in recent years.","market":"nz","thumbnail":"https://www.cityam.com/wp-content/uploads/2026/07/GSK-Cambridge-image-2.jpg?w=824&h=463&crop=1","type":0,"news_type":0,"thumbnails":["https://www.cityam.com/wp-content/uploads/2026/07/GSK-Cambridge-image-2.jpg?w=824&h=463&crop=1"],"rights":{"source":"cityam_highlight","url":"https://www.cityam.com/sweeping-job-cuts-at-gsk-to-fund-400m-cambridge-campus/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.cityam.com/sweeping-job-cuts-at-gsk-to-fund-400m-cambridge-campus/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"cityam_highlight","symbols":["LU1829250122.USD","BK4585","BK4532","BK4588","GSK.UK","GSK","BK4007","GSKH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654400342","title":"GSK’s partner posts positive osteosarcoma data for B7-H3 drug, bolstering oncology push","url":"https://stock-news.laohu8.com/highlight/detail?id=2654400342","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654400342?lang=en_us&edition=fundamental","pubTime":"2026-07-28 18:12","pubTimestamp":1785233546,"startTime":"0","endTime":"0","summary":"The latest update is out from GlaxoSmithKline ( ($GB:GSK) ). GSK’s licensor Hansoh Pharma has reported that its phase III ARTEMIS-011 trial of risv...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsks-partner-posts-positive-osteosarcoma-data-for-b7-h3-drug-bolstering-oncology-push?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsks-partner-posts-positive-osteosarcoma-data-for-b7-h3-drug-bolstering-oncology-push?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1829250122.USD","GSKH","BK4532","BK4588","BK4585","GSK.UK","GSK","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654021060","title":"GlaxoSmithKline (GSK) Receives a Hold from Deutsche Bank","url":"https://stock-news.laohu8.com/highlight/detail?id=2654021060","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654021060?lang=en_us&edition=fundamental","pubTime":"2026-07-28 08:55","pubTimestamp":1785200119,"startTime":"0","endTime":"0","summary":"Deutsche Bank analyst Emmanuel Papadakis reiterated a Hold rating on GlaxoSmithKline yesterday and set a price target of p1,950.00. According to Ti...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/glaxosmithkline-gsk-receives-a-hold-from-deutsche-bank-blurbs-news-4?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/glaxosmithkline-gsk-receives-a-hold-from-deutsche-bank-blurbs-news-4?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4118","BK4532","GSK.UK","BK4007","GSK","BK4566","DB","BK4585","BK4552","GSKH","LU1829250122.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654447210","title":"GSK’s ViiV Healthcare presents data from Phase IIIb VOGUE study","url":"https://stock-news.laohu8.com/highlight/detail?id=2654447210","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654447210?lang=en_us&edition=fundamental","pubTime":"2026-07-28 01:05","pubTimestamp":1785171922,"startTime":"0","endTime":"0","summary":"ViiV Healthcare announced data to be presented this week at the 26th International AIDS Conference in Rio de Janeiro, Brazil, from the phase IIIb V...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/gsks-viiv-healthcare-presents-data-from-phase-iiib-vogue-study-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/gsks-viiv-healthcare-presents-data-from-phase-iiib-vogue-study-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0029874061.USD","BK4137","GSK.UK","HCSG","XBI","XLV","LABU","GSKH","EWZS","GSK","BK4588","LU0128526141.USD","BK4007","LU1829250122.USD","BK4581","BK4532","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654408043","title":"GSK Strategy Update in Focus","url":"https://stock-news.laohu8.com/highlight/detail?id=2654408043","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654408043?lang=en_us&edition=fundamental","pubTime":"2026-07-27 21:42","pubTimestamp":1785159720,"startTime":"0","endTime":"0","summary":"GSK is scheduled to report results for the second quarter on Tuesday. Here is what you need to know.TURNOVER FORECAST: Analysts expect the U.K. drugmaker to generate turnover of 8.24 billion pounds ($","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1829250122.USD","GSKH","BK4532","BK4588","BK4585","GSK.UK","GSK","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653308107","title":"GSK Canada Wins Approval for Prefilled Shingrix Syringe","url":"https://stock-news.laohu8.com/highlight/detail?id=2653308107","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653308107?lang=en_us&edition=fundamental","pubTime":"2026-07-24 19:56","pubTimestamp":1784894167,"startTime":"0","endTime":"0","summary":"GSK  said Friday that Health Canada approved a prefilled syringe presentation of its shingles vaccine, Shingrix, eliminating the need to reconstitute separate vials before administration.The company said the approval was based on data demonstrating technical comparability between the new prefilled syringe and the existing presentation.GSK said it expects the new format to become available in Canada in early 2027.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1829250122.USD","BK4588","BK4007","BK4532","BK4585","GSK","GSK.UK","GSKH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653890280","title":"GSK Plc Expected to Post Earnings of $1.24 a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2653890280","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653890280?lang=en_us&edition=fundamental","pubTime":"2026-07-24 19:22","pubTimestamp":1784892126,"startTime":"0","endTime":"0","summary":"GSK plcexpected to post earnings of $1.24 a share - Earnings PreviewGSK plcGSK.N,GSKis expected to  show a rise in quarterly revenue when it reports  results on July 28 for the period ending June 30 2026The Brentford Hounslow-based  company is expected to report a 3.0% increase in revenue to $10.981 billion from $10.66 billion a year ago, according to the mean estimate from 3 analysts, based on LSEG data.LSEG's mean analyst estimate for GSK plc is for earnings of $1.24 per share.The current average analyst rating on the shares is \"buy\" and the breakdown of recommendations is 5 \"strong buy\" or \"buy,\" 4 \"hold\" and 1 \"sell\" or \"strong sell.\"The mean earnings estimate of analysts was unchanged in the last three months. Wall Street's median 12-month price target for GSK plc is $54.00, about 6.4% above its last closing price of $50.74This summary was machine generated July 24 at 11:22 GMT.  All figures in US dollars unless otherwise stated.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260724:nL8N43Q0ZR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","SG9999013999.USD","LU1228905540.USD","SG9999001176.USD","LU1400636574.HKD","LU1098665638.USD","LU1015430645.USD","LU1035777561.USD","LU1400636657.SGD","BK5011","BK4007","LU1481600234.SGD","SG9999001176.SGD","LU0203345920.USD","LU0321505439.SGD","BK4588","LU0971552830.HKD","LU0225284248.USD","LU0985481810.HKD","LU1829250122.USD","LU1228905037.USD","LU2468319806.SGD","LU0321505868.SGD","LU1309081286.SGD","LU1046248800.SGD","LU0289739699.SGD","LU0306807586.USD","LU1400636491.USD","GSK","IE00B3T34201.USD","LU0545562505.USD","LU0575583348.USD","LU1983299246.USD","SGXZ57979304.SGD","LU2646069778.SGD","LU0211331839.USD","GSKH","LU1064927863.SGD","LU1202635105.USD","IE0034235071.USD","LU0109981661.USD","IE00BQJZX424.USD","IE00BWDBJ516.SGD","LU0161305163.EUR","GSK.UK","LU1481599808.USD","LU0225283273.USD","LU2089984988.USD","LU0225771236.USD","LU0987226296.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653760063","title":"Sector Update: Healthcare Stocks Softer Late Afternoon","url":"https://stock-news.laohu8.com/highlight/detail?id=2653760063","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653760063?lang=en_us&edition=fundamental","pubTime":"2026-07-23 03:48","pubTimestamp":1784749691,"startTime":"0","endTime":"0","summary":"Healthcare stocks declined late Wednesday afternoon, with the NYSE Healthcare Index down 0.4% and the State Street Health Care Select Sector SPDR ETF (XLV) shedding 0.5%.The iShares Biotechnology ETF ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4532","BK4534","IE00B2B36J28.USD","AMGN","LU0205194284.USD","LU2112291526.USD","LU1023059063.AUD","LU1169589451.USD","IBBQ","PJP","XBI","BBH","TBXU","BIB","BK4588","BK4137","GSKH","IE00BJT1NW94.SGD","IE00B4R5TH58.HKD","GSK.UK","IBB","LU0058720904.USD","LU0106261612.USD","LU0289739699.SGD","LU2468319806.SGD","BK4599","BK4121","GSK","LABU","LU0029874061.USD","LU1829250122.USD","LU1983299246.USD","BK4139","PBE","LU0109394709.USD","ARWR","LU0320765992.SGD","LU1061106388.HKD","LU0128526141.USD","HCSG","BK4198","LU0868494617.USD","LU1169590202.USD","BK4533","XLV","BLFS","BK4581","BK4566","RGEN","LU2242652126.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653176475","title":"GSK Gets U.S. Approval for Jideytro for Certain Lung Cancers","url":"https://stock-news.laohu8.com/highlight/detail?id=2653176475","media":"Dow Jones","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653176475?lang=en_us&edition=fundamental","pubTime":"2026-07-23 01:03","pubTimestamp":1784739780,"startTime":"0","endTime":"0","summary":"GSK said its Jideytro treatment has been approved by the U.S. Food and Drug Administration, making it the U.K. drug maker's first approved medicine in lung cancer.Jideytro, or zidesamtinib, is a selective inhibitor for some adult patients with non-small cell lung cancer who previously received a targeted therapy.The treatment is part of the portfolio GSK acquired in its purchase of Nuvalent earlier this year.Write to Sarah Sloat at sarah.sloat@wsj.com Dow Jones NewswiresJuly 22, 2026 13:03 ET Copyright  2026 Dow Jones & Company, Inc.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"GSK Gets U.S. Approval for Jideytro for Certain Lung Cancers","news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU1829250122.USD","GSK","BK4532","GSKH","BK4007","GSK.UK","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653204892","title":"GSK’s New Malaria Candidate Advances With Key Drug-Interaction Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2653204892","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653204892?lang=en_us&edition=fundamental","pubTime":"2026-07-22 00:30","pubTimestamp":1784651422,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ($GSK) announced an update on their ongoing clinical study. GlaxoSmithKline is running a Phase 1 study called “A Phase 1, Open-Labe...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsks-new-malaria-candidate-advances-with-key-drug-interaction-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsks-new-malaria-candidate-advances-with-key-drug-interaction-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","GSK","GSK.UK","BK4532","BK4588","GSKH","LU1829250122.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653021208","title":"GSK’s ViiV Healthcare to present new data on INSTI-focused portfolio","url":"https://stock-news.laohu8.com/highlight/detail?id=2653021208","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653021208?lang=en_us&edition=fundamental","pubTime":"2026-07-21 21:25","pubTimestamp":1784640316,"startTime":"0","endTime":"0","summary":"GSK (GSK) announced that ViiV Healthcare announced new clinical and real-world data highlighting its integrase strand transfer inhibitor, INSTI, -f...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/gsks-viiv-healthcare-to-present-new-data-on-insti-focused-portfolio-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/gsks-viiv-healthcare-to-present-new-data-on-insti-focused-portfolio-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4532","HCSG","LU0128526141.USD","LU1829250122.USD","GSKH","BK4581","BK4137","BK4588","XLV","LABU","BK4585","GSK","LU0029874061.USD","GSK.UK","XBI","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653761245","title":"GSK plc Stock (GSK) Closed Down by 3.17% on Jul 20: Facts Behind the Movement","url":"https://stock-news.laohu8.com/highlight/detail?id=2653761245","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653761245?lang=en_us&edition=fundamental","pubTime":"2026-07-21 04:15","pubTimestamp":1784578519,"startTime":"0","endTime":"0","summary":"• GSK stock faces downward pressure from ongoing Zantac litigation liabilities and regulatory uncertainty.\n• Heightened competition in vaccine markets and rising research costs impact investor sentiment.\n• Technical indicators, including Williams %R, signal potential selling pressure for the stock.","market":"other","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262042313-market-movers-gsk-20260720","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GSK","BK4532","GSK.UK","GSKH","BK4585","BK4007","LU1829250122.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653217133","title":"GSK Updates Key Pediatric Flu Study, Signaling Quiet Upside for Its Antiviral Portfolio","url":"https://stock-news.laohu8.com/highlight/detail?id=2653217133","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653217133?lang=en_us&edition=fundamental","pubTime":"2026-07-21 00:30","pubTimestamp":1784565011,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ($GSK) announced an update on their ongoing clinical study. GlaxoSmithKline has updated a key pediatric study on its IV flu drug za...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-updates-key-pediatric-flu-study-signaling-quiet-upside-for-its-antiviral-portfolio?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-updates-key-pediatric-flu-study-signaling-quiet-upside-for-its-antiviral-portfolio?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSK.UK","GSKH","GSK","BK4588","BK4007","LU1829250122.USD","BK4532","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652297452","title":"GSK announces EMA accepted submission to update Bexsero label","url":"https://stock-news.laohu8.com/highlight/detail?id=2652297452","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652297452?lang=en_us&edition=fundamental","pubTime":"2026-07-20 18:40","pubTimestamp":1784544023,"startTime":"0","endTime":"0","summary":"GSK (GSK) announced the European Medicines Agency, EMA, has accepted a submission to update the label for Bexsero to include a single dose booster ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/gsk-announces-ema-accepted-submission-to-update-bexsero-label-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/gsk-announces-ema-accepted-submission-to-update-bexsero-label-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GSK","BK4532","GSKH","EMA","EPV","LU1829250122.USD","BK4585","BK4007","BK4081","GSK.UK","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652426246","title":"GSK Cough Drug Failure Disappoints, but Market was Cautious","url":"https://stock-news.laohu8.com/highlight/detail?id=2652426246","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652426246?lang=en_us&edition=fundamental","pubTime":"2026-07-20 13:38","pubTimestamp":1784525880,"startTime":"0","endTime":"0","summary":"0538 GMT - News that a GSK experimental drug for chronic cough achieved negative results in late-stage studies is disappointing, but the market was cautious on the product's chances, Citi analysts say in a research note. Some saw in the drug, camlipixant, a potential candidate to help the U.K. drugmaker offset the patent expiration of its dolutegravir HIV medication, the analysts say. Still, Citi saw the drug as a high-risk asset and assigned it a 25% probability of success in its estimates, equivalent to just 1% of expected GSK revenue for 2035, they add. Similarly, consensus was cautious, with estimated 2035 sales of 750 million pounds for camlipixant accounting for 2% of group revenue, according to Citi. GSK shares closed 2% lower on Friday.  Dow Jones NewswiresJuly 20, 2026 01:38 ET Copyright  2026 Dow Jones & Company, Inc.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GSK.UK","BK4588","BK4532","BK4585","BK4007","LU1829250122.USD","GSKH","GSK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652233088","title":"Dow Jones Top Company Headlines at 7 PM ET: Walmart Further Shuffles Top Executives | SpaceX ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2652233088","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652233088?lang=en_us&edition=fundamental","pubTime":"2026-07-18 07:00","pubTimestamp":1784329200,"startTime":"0","endTime":"0","summary":"Walmart Further Shuffles Top ExecutivesKieran Shanahan, chief operating officer for Walmart U.S., will leave this week.----SpaceX in Talks to Provide Computing Power for Pentagon's AI PushElon Musk's company would provide billions of dollars' worth of data-center capacity under the arrangement, people familiar with the matter said.----Nvidia, Challenged by Apple, Narrowly Retains Wall Street's CrownThe iPhone maker briefly became the U.S.'s most valuable publicly traded company on Friday.----China's Moonshot AI Releases Model to Challenge Top U.S. SystemsThe company says its model outperforms some cutting-edge U.S. systems, the latest sign that Chinese labs can rival American counterparts.----Taylor Farms Is Recalling Its Mexican-Grown Iceberg Lettuce From U.S.U.S. authorities have linked the lettuce to a parasitic outbreak across more than 30 states.----Travelers Scored an Earnings Beat. Were the Downgrades All Wrong?","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IETC","LU0476273544.USD","LU0823417737.USD","LU0203347892.USD","XLK","LU2095319765.USD","LU2097344431.USD","LU2237957811.SGD","SG9999014898.SGD","LU0889565833.HKD","BK4501","BK4170","LU1988902786.USD","LU0211327993.USD","LU1674673691.USD","LU2384288077.EUR","LU0109392836.USD","NVDX","BK4604","NVDQ","LU2746668974.SGD","DFNL","LU0345768153.USD","LU0210528500.USD","LU1989772840.SGD","IE0004445015.USD","LU2896262040.SGD","IE0001KFT4U8.USD","LU0557290698.USD","GSK.UK","AMZZ","LU0225283273.USD","LU2471134523.USD","LU1066051498.USD","LU2471134879.HKD","IE00BJLML261.HKD","LU0957808578.USD","LU2247934214.USD","TRV","LU1880398554.USD","IE00BZ1G4Q59.USD","LU0175139822.USD","HK0000306685.HKD","LU1564329032.USD","LU0342679015.USD","LU1670711123.USD","BK4571","LU0345769631.USD","LU1670711040.USD","METV","LU2462157665.USD","LU0868494708.USD","IE00BBT3K403.USD","FBL","BK4592","LU2168564495.EUR","LU2462591350.SGD","LU0310800379.SGD","LU2211817866.USD","LU1829250122.USD","BK4207","LU0162691827.USD","LU1935042488.USD","LU1791710400.SGD","ANV","IE00BK4W5L77.USD","LU2148611432.USD","IE000KEQY171.SGD","LU0795875169.SGD","LU0345774391.USD","LU1116320737.USD","NVDA","LU1127390331.HKD","LU1145028129.USD","LU1861220033.SGD","CLIX","HK0000819398.USD","SG9999015986.USD","LU0648000940.SGD","LU2125909759.SGD","LU2999663052.SGD","BK4614","SG9999014880.SGD","IE00BD6J9T35.USD","IE0000B7K699.USD","BK4579","LU1861559042.SGD","IE00BLSP4239.USD","LU0444971666.USD","LU1261432733.SGD","LU2125154778.USD","LU0323591593.USD","LU0689626769.HKD","LU0138981039.USD","FTXO","LU1720051108.HKD","LU0097036916.USD","AZYY","LU1621767737.EUR","BK4581","LU1069347547.HKD","LU1301847155.USD","IE00BFXG1179.USD","NVDS","LU0552385451.USD","BK4573","GSKH","LU0079474960.USD","GB00B4QBRK32.GBP","LU0211328371.USD","BK4587","LU0289739343.SGD","LU1868836591.USD","LU0068578508.USD","LU0320765489.SGD","LU2294711713.HKD","LU2322448957.HKD","BK4597","IE00BFXG0V08.USD","LU1623119135.USD","AAPD","LU0072461881.USD","LU0345769128.USD","LU2211815571.USD","XLC","LU2275660780.HKD","LU1923622614.USD","WMT","USD","LU1868836757.USD","LU1914381329.SGD","LU0238689110.USD","LU0823411888.USD","LU2463028550.USD","IE00BK4W5M84.HKD","LU0174119429.USD","LU1064131342.USD","LU1935043536.SGD","LU2108987350.USD","LU1267930490.SGD","SG9999001077.SGD","LU2543165471.USD","BK4543","IE00B19Z3B42.SGD","BK4551","IE00BJTD4N35.SGD","IE000ITXATA3.USD","IE00BMPRXN33.USD","LU0345768740.USD","LU1621768115.EUR","TRFK","LU1119994496.HKD","LU0494093205.USD","AAPU","LU0965509283.SGD","GB00BDT5M118.USD","LU1861215975.USD","IE00BKPKM429.USD","LU2028103732.USD","LU0158827781.USD","IE00B19Z8X17.USD","LU2360032135.SGD","BK4512","LU0683600562.USD","LU2756315664.SGD","LU2357125470.USD","IE00B775SV38.USD","IE00B3SWFQ91.USD","LU1868836914.USD","LU2326559502.SGD","SGXZ81514606.USD","BK4077","LU0149725797.USD","LU0306807586.USD","LU2491049909.HKD","IE00BLSP4452.SGD","LU1821325948.USD","LU0433182093.SGD","SGXZ31699556.SGD","LU0323240290.USD","LU2272731865.HKD","KBWB","SG9999014575.USD","LU2111349929.HKD","BK4115","LU1917777945.USD","IE00BFSS8Q28.SGD","LU0320765646.SGD","LU2089284900.SGD","BK4553","LU0077335932.USD","HK0000532082.HKD","LU2433249047.HKD","IE00BHPRN162.USD","LU2347655073.USD","BK4122","LU0823414478.USD","LU0949170426.SGD","LU2125909916.SGD","LU2362540622.SGD","LU1935042991.SGD","LU0823417653.USD","LU1074936037.SGD","BK4503","LU0823421333.USD","LU1935043023.USD","LU2210150020.SGD","BK4554","APLY","LU1116320901.HKD","AIFD","LU2381873111.SGD","LU0784384876.USD","LU2413666426.HKD","IE000BZT7R73.USD","SG9999015978.USD","LU0053666078.USD","LU2100268510.USD","TEK","LU0820562030.AUD","LU0234570918.USD","LU0354030438.USD","LU0724617625.USD","LU0943347566.SGD","LU1791710582.SGD","LU2237443465.HKD","LU2452424414.USD","LU0289960550.SGD","LU0964807845.USD","LU2125909247.SGD","LU2210149790.SGD","LU1059921491.USD","AAPW","LU0354030511.USD","AAPL","LU1244550494.USD","LU1645745479.HKD","NVDU","2NVD.UK","LU0208291251.USD","LU2394011477.USD","FCOM","LU0061474960.USD","LU2237443549.SGD","IE000W1ABFV2.USD","BK4596","BK4507","VZ","SG9999014906.USD","LU0011850046.USD","LU1989764748.USD","IE00BKDWB100.SGD","SOCL","LU0323239441.USD","IE00BQXX3D17.EUR","LU2360107168.USD","LU0528227936.USD","LU2242650005.HKD","IE0034235303.USD","BK4532","LU0048573561.USD","BK4220","LU0080751232.USD","LU1035773651.USD","LU2106854487.HKD","LU2430703178.SGD","GB00B4LPDJ14.GBP","USXF","LU0170899867.USD","LU2552382132.HKD","LU2505996509.AUD","LU0690374961.EUR","LU0133085943.USD","IE000MB6IJN5.SGD","FITB","LU0444973449.USD","LU1670627923.USD","LU0082616367.USD","NULC","LU2473716301.USD","LU0107464264.USD","LU0316494557.USD","LU2089985449.USD","LU2764262908.HKD","LU0210536198.USD","LU1951198990.SGD","LU0312595415.SGD","LU1621767810.EUR","LU1670628061.USD","AMZU","SG9999014567.USD","LU1548497426.USD","LU2244417387.USD","IE00BDRTCR15.USD","LU1629891620.HKD","IE00B19Z8W00.USD","IE0004086264.USD","IE000M9KFDE8.USD","LU0225284248.USD","IE00BWXC8680.SGD","LU1084165304.USD","BK4585","IE00BMPRXQ63.HKD","IE00BYXW3230.USD","LU1571399168.USD","IE0005OL40V9.USD","LU1814569148.SGD","ONLN","IE00B4YYXB79.USD","IE00B5949003.HKD","BK4155","CMA","KBWP","LU1699723380.USD","AMZY","LU1206713676.USD","LU2417539215.USD","LU0266013472.USD","LU1242518931.SGD","LU1633808545.USD","IE00B1BXHZ80.USD","LU1868837300.USD","LU0949170772.SGD","LU1989764664.SGD","SG9999004303.SGD","BK4598","LU0820561909.HKD","SNPE","LU0708995401.HKD","BK4605","LU2168564149.EUR","LU2168563687.JPY","LU2092627202.USD","GSK","LU0985481810.HKD","SG9999001424.SGD","JGRO","LU0251131958.USD","IE00BJJMRY28.SGD","LU2264538146.SGD","FAI","LU1366333091.USD","LU1496350502.SGD","LU0302445910.USD","LU0784383803.USD","LU2461242641.AUD","CNEQ","SG9999002232.USD","LU2458330169.SGD","SOXY","LU2361044865.SGD","IE00B7SZLL34.SGD","LU0719512351.SGD","SPTE","LU0308772762.SGD","BK4505","LU1582987324.SGD","CHAT","IE00B775H168.HKD","IYZ","LU1435385759.SGD","BK4549","IE00BYQQ9H92.USD","LU0203202063.USD","LU2286300806.USD","NVDY","LU2860962120.EUR","LU0353189763.USD","LU1778281490.HKD","LU2362541513.USD","LU1974910355.USD","IE00BMPRXR70.SGD","LU0061475181.USD","LU0081259029.USD","LU1989771016.USD","LU0553294199.USD","SG9999015358.SGD","IE00BKVL7J92.USD","ILDR","LU2322448791.USD","LU2249611893.SGD","LU2265009873.SGD","LU2404859667.USD","LU2506951792.HKD","LU1280957306.USD","LU2063271972.USD","SG9999015952.SGD","LU1003077747.HKD","LU1232071149.USD","LU0786609619.USD","LU0320765059.SGD","LU0672654240.SGD","LU0690374615.EUR","LU2750360997.AUD","LU0158827948.USD","UGE","OGIG","LU1721428933.USD","SG9999017495.SGD","LU2047632596.USD","LU0006306889.USD","LU2065171311.SGD","LU0942090050.USD","XDAT","IE000Q6AESB8.SGD","SG9999000418.SGD","LU2413666699.HKD","SG9999014542.SGD","LU1582986359.USD","BK4548","LU0321505439.SGD","LU0784385840.USD","LU0234572021.USD","LU1244550221.USD","LU0472753341.HKD","LU2430703095.HKD","SGXZ99366536.SGD","LU0648001328.SGD","LU0417517546.SGD","LU2420271590.USD","LU2317271919.USD","LU0784385170.HKD","BK4527","LU2237443978.SGD","LU1242518857.USD","LU0788109477.HKD","LU0823434583.USD","LU0289941410.SGD","3NVD.UK","SOXQ","LU0738911758.USD","LU2087621335.USD","LU1697837992.HKD","LU0072462426.USD","NVDW","IE00BN8TJ469.HKD","LU2065171402.SGD","IE000YTNTUN2.SGD","IE00B1XK9C88.USD","LU0265550359.USD","LU1046421795.USD","IE00BN29S564.USD","LU2487616109.SGD","BK4574","ROM","LU0640476718.USD","LU1852331112.SGD","IE0034235188.USD","LU1267930730.SGD","LU0353189680.USD","LU0871640123.AUD","LU0070302665.USD","BK4007","LU1400636657.SGD","LU2357305700.SGD","LU1291159041.SGD","LU1868837136.USD","LU1201861249.SGD","LU0056508442.USD","LU1732800096.USD","LU1712237335.SGD","LU0823434740.USD","LU1316542783.SGD","LU2403377893.USD","BK4529","AGOX","BK4533","LU0198837287.USD","LU1670710588.SGD","LU1839511570.USD","SHOC","LU1880398471.USD","LU1674673428.USD","LU1718418525.SGD","CLSE","AIPI","HK0000304797.USD","BK4107","IE00B4JS1V06.HKD","LTL","LU0203201768.USD","LU0251132253.USD","LU1489326972.SGD","LU1861127337.USD","LU2242649171.HKD","LU2430703251.USD","RTH","LU0820561818.USD","LU2491050154.USD","IE00BQXX3C00.GBP","LU1323610961.USD","HK0000306701.USD","LU2083900584.USD","LU0215105999.USD","SG9999018857.SGD","LU2552382215.SGD","LU0096364046.USD","LU1815333072.USD","META","LU0251142724.SGD","LU1992135472.HKD","NVD2.UK","LU0289961442.SGD","LU2023250330.USD","AMZP","BK4504","LU2954938101.SGD","LU1923623000.USD","HK0000320264.USD","LU0310799852.SGD","LU2077746001.SGD","LU2750360641.GBP","LU0187121727.USD","LU2404859741.USD","IE000F7OJYX1.SGD","LU2360106780.USD","USAW.SI","LU1206712785.SGD","SG9999002224.SGD","LU0256863811.USD","LU2272731782.SGD","LU0098860793.USD","HK0000304805.HKD","IE00B19Z3581.USD","LU0314104364.USD","LU0661504455.SGD","LU0795875086.SGD","LU2168564222.USD","LU2237438978.USD","LU0057025933.USD","LU1400636574.HKD","LU1621768206.USD","LU2462591277.SGD","SG9999015341.SGD","LU2065169927.USD","LU1564329115.USD","LU2133065610.SGD","LU0787776722.HKD","LU0965509101.SGD","METD","IE00BFSS7M15.SGD","BK4589","LU1037948897.HKD","LU1935042215.USD","NVDD","BK4524","LU2125909593.SGD","IE000SO60NU8.SGD","LU0726765562.USD","LU0348723411.USD","NVD3.UK","LU0823421416.USD","NVDO","LU0511384066.AUD","RSPC","LU1066051811.HKD","LU2602419157.SGD","LU1366192091.USD","NVYY","LU2237443382.USD","SGXZ51526630.SGD","LU2087625088.SGD","VGT","AAPY","LU1923622291.USD","LU0882574139.USD","LU1267930573.SGD","LU2637965513.SGD","NVDL","LU0985489474.SGD","SG9999014559.SGD","IXN","TFC","NVDS.UK","HK0000914660.USD","LU0545039389.USD","IE00BQXX3F31.USD","LU2023250843.SGD","SG9999018865.SGD","LU1823568750.SGD","LU2931357623.SGD","LU1691799644.USD","LU2458330243.SGD","LU1582987597.SGD","BK4535","BK4608","LU1244550577.SGD","LU0127658192.USD","LU2097829019.USD","LU3102509885.SGD","LU2756315318.SGD","MACW.SI","IE0009G5SDU7.USD","LU1066051225.USD","LU2250418816.HKD","LU1551013425.SGD","SGXZ23171101.USD","LU1069344957.HKD","FDTX","LU0642271901.SGD","LU2237443895.HKD","LU2054465674.USD","LU0950375773.USD","LU2023250504.SGD","LU0957791311.USD","FTEC","LU0466842654.USD","LU0980610538.SGD","LU1934455863.HKD","LU1564329461.SGD","LU2456880835.USD","LU1235294995.USD","LU2764263039.SGD","IE00B3S45H60.SGD","LU2089283258.USD","LU0211331839.USD","LU1551013342.USD","LU2746668461.USD","BK4538","LU2236285917.USD","VT","IAK","SMHX","IE00BJJMRX11.SGD","BK4515","LU1153585028.USD","LU0109391861.USD","LU0210533765.USD","DIPS","HK0000914686.HKD","IE00B3M56506.USD","BK4567","LU0321505868.SGD","BK4575","IE00BZ199S13.USD","LU2471134796.USD","LU2592432038.USD","LU0256863902.USD","SG9999014914.USD","LU0979878070.USD","LU1585245621.USD","LU0124676726.USD","LU0314106906.USD","LU0456855351.SGD","LU0823414551.USD","LU0912757837.SGD","LU0742534661.SGD","LU1934455277.USD","LU1989772923.USD","LU1670756490.USD","LU2506952097.USD","IE000WAW04H5.SGD","LU0106261372.USD","LU2764263203.CNY","IE00BDCRKT87.USD","LU0265550946.USD","LU1506573853.SGD","LU1983260115.SGD","LU1861558580.USD","FBY","AMZW","LU0029864427.USD","LU0096362180.USD","LU1815336760.USD","LU2362541273.HKD","LU2506952170.USD","IE00B7KXQ091.USD","LU0143551892.USD","LU0390134368.USD","LU2290526834.HKD","LU2191332357.HKD","TTEQ","LU1582986433.USD","LU1201861165.SGD","LU2125154935.USD","LU1804176565.USD","NVII","SNVD.UK","IE00B19Z9505.USD","AAPX","METW","LU0128525929.USD","ARTY","07388","LU2347655156.SGD","07788","LU0048584097.USD","LU2505996681.GBP","IE0003U64NQ7.SGD","LU0267386448.USD","LU1564329628.SGD","AMZD","NVIW.SI","SOXX","BK4141","WANT","LU2023251221.USD","BK4612","BK4576","LU1162221912.USD","BK4559","IE0034235295.USD","LU2506951958.HKD","AMZN","LU0094547139.USD","LU1035775433.USD","LU1496350171.SGD","LU1720051017.SGD","LU2271345857.HKD","HK0000320223.HKD","LU0708994859.HKD","NVD","WMTI","LU1430594728.SGD","NVDB","IAT","FBYY","LU1883839398.USD","LU2471134952.CNY","LU0061474705.USD","LU1803068979.SGD","LU0861579265.USD","LU0689472784.USD","LU0878866978.SGD","IE0009356076.USD","LU0965509010.AUD","LU0985320562.USD","LU0203345920.USD","LU2065170008.USD","LU2097344357.USD","LU1732799900.SGD","TYLG","LU2237443622.USD","FSTA","IE0004445239.USD","LU0345774631.USD","LU1951200564.SGD","LFGY","LU1429558221.USD","BK4534","LU0345770308.USD","LU1037948541.HKD","LU0965508806.USD","LU1202635105.USD","METU","IE00BJTD4V19.USD","LU0274383776.USD","LU0276348264.USD","IE0004091025.USD","LU2092937148.SGD","LU0345770993.USD","LU2361044949.HKD","LU2361045086.USD","LU0157215616.USD","LU0306806265.USD","LU2552382058.USD","LU0225771236.USD","IE00B5TLWC47.USD","LU0154236417.USD","SMH","LU1934455194.USD","LU2491050071.SGD","LU0070217475.USD","LU0868494617.USD","LU2506951875.HKD","LU0069063385.USD","VOX","XLP","BK4588","ABFL","LU0347712357.USD","IE0002270589.USD","LU2213496289.HKD","LU0130102774.USD","LU1400636491.USD","ESUM","LU1992135399.USD","LU1670710661.SGD","AAPB","LU2237957902.USD","BK4550","BK4566","LU1066053197.SGD","LU2168564065.EUR","LU2272731600.USD","WISE","BK4211","LU1642822529.SGD","EFIV","BK4561","LU2720916845.USD","NVDG","IE00BSNM7G36.USD","LU0130103400.USD","SG9999015945.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652128784","title":"GSK plc Stock (GSK) Moved Down by 3.06% on Jul 17: Drivers Behind the Movement","url":"https://stock-news.laohu8.com/highlight/detail?id=2652128784","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652128784?lang=en_us&edition=fundamental","pubTime":"2026-07-18 02:15","pubTimestamp":1784312115,"startTime":"0","endTime":"0","summary":"• GSK shares face volatility due to ongoing Zantac litigation and potential settlement liabilities.\n• Industry pricing pressures and shifting institutional investment contribute to downward stock performance.\n• Uncertain clinical pipeline results and currency fluctuations impact the company's valuation and earnings.","market":"us","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262038442-market-movers-gsk-20260717","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1829250122.USD","BK4585","BK4532","BK4588","GSK.UK","GSK","BK4007","GSKH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652840282","title":"GSK’s ALANIS Trial: Fresh Momentum in AL Amyloidosis Could Reshape Investor Views","url":"https://stock-news.laohu8.com/highlight/detail?id=2652840282","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652840282?lang=en_us&edition=fundamental","pubTime":"2026-07-18 00:32","pubTimestamp":1784305947,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ($GSK) announced an update on their ongoing clinical study. The ALANIS study from GlaxoSmithKline (GSK) is a Phase 2 trial testing ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsks-alanis-trial-fresh-momentum-in-al-amyloidosis-could-reshape-investor-views?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsks-alanis-trial-fresh-momentum-in-al-amyloidosis-could-reshape-investor-views?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1169589451.USD","GSK","BK4588","GSK.UK","IE00B19Z6F94.USD","BK4007","IE0034390439.USD","LU1169590202.USD","BK4572","AL","BBC","GSKH","BK4104","LU1829250122.USD","PSIL","BK4532","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652073284","title":"GSK Explores Heart Health Upside From Its Next-Gen Vaccines","url":"https://stock-news.laohu8.com/highlight/detail?id=2652073284","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652073284?lang=en_us&edition=fundamental","pubTime":"2026-07-18 00:31","pubTimestamp":1784305901,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ($GSK) announced an update on their ongoing clinical study. GSK tests vaccines for heart risk in adults 50+. The study, “A Randomiz...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-explores-heart-health-upside-from-its-next-gen-vaccines?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-explores-heart-health-upside-from-its-next-gen-vaccines?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","GSK.UK","BK4007","BK4585","GSKH","LU1829250122.USD","BK4532","GSK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652284045","title":"GSK’s New Asthma Injection Study: Early Signals for Long-Term Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2652284045","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652284045?lang=en_us&edition=fundamental","pubTime":"2026-07-18 00:31","pubTimestamp":1784305861,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ($GSK) announced an update on their ongoing clinical study. GSK Bioavailability Trial Offers Fresh Insight for Asthma Investors. Th...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsks-new-asthma-injection-study-early-signals-for-long-term-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsks-new-asthma-injection-study-early-signals-for-long-term-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ISBC","BK4007","BK4588","GSK","LU1829250122.USD","GSK.UK","BK4585","BK4532","BK4211","GSKH"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":200,"code":"91000000","status":"200"}]}}